A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC.

Name: A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC.
Author: Melosky, Barbara L

A phase II trial of the effect of perindopril on hand-foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC. — المؤلف: Melosky, Barbara L — Cancer chemotherapy and pharmacology 20191231

المؤلف: Melosky, Barbara L
النشر: Cancer chemotherapy and pharmacology 20191231
الوصف: 411-417 p.
الموضوعات: Aged؛ Angiotensin-Converting Enzyme Inhibitors؛ Colorectal Neoplasms؛ Drug Resistance, Neoplasm؛ Female؛ Hand-Foot Syndrome؛ Humans؛ Incidence